Publications Office of the EU
Romania-Bucuresti: Antineoplastic and immunomodulating agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Romania-Bucuresti: Antineoplastic and immunomodulating agents

Overview
  • Awarded
    13/11/2014
  • Today
    06/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Not available
Place of performance
NUTS code: RO321 Bucureşti
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33652000 33652000
Total estimated contract value (excluding VAT)
180,450.20
Total final contract value (excluding VAT)
3,129,161.30 RON
Procedure details
Tender reference number
49705/10.11.2014
Description

Supply of cancer medicines.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
RO321 Bucureşti
CPV code

33652000 - 33652000

Award method
Lowest price
Estimated value
180,450.20
Final contracted value
3,129,161.30 RON
Award of contract
Official name: Actavis SRL
Postal address: B-dul Ion Mihalache nr. 11, sector 1
Town: Bucuresti
Postal code: 011171
Country: ROU
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.